Bay Harbor Wealth Management’s ResMed RMD Stock Holding History

Bay Harbor Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.31K	Sell	17 -14	-45%	-$2.9K	﹤0.01%	523
2026 Q1	$6.96K	Buy	31 +7	+29%	+$1.74K	﹤0.01%	286
2025 Q4	$5.78K	Buy	24 +2	+9%	+$511	﹤0.01%	260
2025 Q3	$6.02K	Hold	22	–	–	﹤0.01%	180
2025 Q2	$5.68K	Buy	22 +3	+16%	+$716	﹤0.01%	170
2025 Q1	$4.25K	Buy	19 +6	+46%	+$1.4K	﹤0.01%	145
2024 Q4	$2.97K	Hold	13	–	–	﹤0.01%	145
2024 Q3	$3.17K	Buy	13 +5	+63%	+$1.12K	﹤0.01%	136
2024 Q2	$1.53K	Buy	+8	New	+$1.62K	﹤0.01%	156
2020 Q1	–	Sell	-12	Closed	-$2K	–	395
2019 Q4	$2K	Hold	12	–	–	﹤0.01%	296
2019 Q3	$2K	Buy	+12	New	+$1.57K	﹤0.01%	310

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bay Harbor Wealth Management's RMD Position: Q2 2026 in Review

Bay Harbor Wealth Management reduced its ResMed (RMD) stake by 45% in Q2 2026, selling an estimated $2.9K and leaving 17 shares worth $3.31K. The position accounts for ﹤0.01% of the portfolio, ranked #523.

Bay Harbor Wealth Management first reported a position in RMD in Q3 2019 and has held it in 11 quarters since. The position peaked at $6.96K in Q1 2026. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Bay Harbor Wealth Management held 17 shares of ResMed worth $3.31K as of Q2 2026.
Bay Harbor Wealth Management sold 14 ResMed shares in Q2 2026, an estimated $2.9K.
ResMed made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #523 holding.
Bay Harbor Wealth Management first reported a position in ResMed in Q3 2019 and has held it in 11 quarters since.
Bay Harbor Wealth Management's ResMed position peaked at $6.96K in Q1 2026.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.